Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

FDA Yanks Transvaginal Mesh From US Market; Boston Sci 'Surprised'; Firms Have 10 Days To Submit Withdraw Plan

Apr 16 2019

• By Shawn M. Schmitt

Surgical knife and tension-free vaginal tape on lilac background - Image

Related Content

Public Interest Groups Will Leverage ‘Bleeding Edge’ Lessons To Push For Device Safety Changes

Sep 26 2018

US FDA Advisory Committee Recommends 3-Year Benefit-Risk Reviews For Pelvic Mesh

Feb 14 2019

PMA Mandate Set For Pelvic Organ Prolapse Transvaginal Mesh

Jan 04 2016

Related Companies

Boston Scientific Corporation

Additional Topics

Recalls FDA Safety Quality Post Market Regulation & Studies Regulation Gynecology & Urology Medical Device

More from Recalls

More from Policy & Regulation

About Us

About Us
Meet the TeamOpens in new window
RSS FeedOpens in new window
Download the App
Advertise with us

Account

Log in
SubscribeOpens in new window
My Account
My View
Email Alerts
Customer Service
AdvertisingOpens in new window
Feedback

Publications

Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window